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An 82-year-old man presented to the hospital for severe con-
fusion with left-sided facial rash for six days. He was seen by his 
primary care physician when the rash began and was started on 
oral acyclovir. He had never received vaccination against vari-
cella zoster virus (VZV). He experienced multiple falls, wors-
ening confusion, and deteriorating visual impairment of the 
left eye and he was brought to the hospital for further evalu-
ation. On examination, he was disoriented to time and place, 
and family noted the patient to be experiencing intermittent 
visual hallucinations. He had a vesicular rash on an erythem-
atous base with crusted lesions limited to the V1 distribution 
of the left trigeminal nerve. The left eyelids were edematous, 
and were unable to be opened, with conjunctival exudate. He 
was changed to IV acyclovir. Lumbar puncture was performed 
with cerebrospinal fluid (CSF) findings significant for 340 leu-
kocytes/mm3, 25% lymphocytes, 71% monocytes, protein of 229 
mg/dl, and glucose of 42 mg/dl. Rapid VZV PCR was positive. 
He was diagnosed with zoster ophthalmicus complicated by 
meningoencephalitis. His mental status, rash, and visual acu-
ity subsequently began to improve on IV acyclovir. He was 
continued on IV acyclovir for two weeks and had full recovery.
DISCUSSION
The incidence of zoster ophthalmicus is estimated to be 30.6 
per 100,000.1 Ocular complications include keratitis, corneal in-
flammation, uveitis, and eventually blindness which can occur 
in up to two-thirds of patients with late stage disease at pre-
sentation.2 Almost half of patients with zoster ophthalmicus 
can have CSF pleocytosis, and near one-third can have positive 
VZV, even without symptoms of meningitis.3 Monocytosis of 
the CSF is typical for VZV infection.4 IV acyclovir has the best 
CSF penetration and is recommended for those with neurolog-
ic symptoms.5 Lumbar puncture should be performed in zoster 
ophthalmicus if there is high clinical suspicion as it influences 
route and duration of therapy.4 The Infectious Disease Society of 
America recommends treating VZV encephalitis with IV acyclo-
vir at a dose of 10 - 15 mg/kg every eight hours for 10 - 14 days.6
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